Kayoko Shioda1, Lucia Helena de Oliveira2, Jennifer Sanwogou2, Gloria Rey-Benito2, Diana Nuñez Azzad3, Roxana Elizabeth Castillo4, María Liz Gamarra Ramírez5, Marta Raquel Von Horoch6, Daniel M Weinberger7, Virginia E Pitzer7. 1. Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut 06520-8034, USA. Electronic address: kayoko.shioda@yale.edu. 2. Immunization Unit, Pan American Health Organization, Washington DC 20037, USA. 3. Jefa Unidad de Vigilancia de la Salud, Secretaria de Salud- Honduras, Avenida Miguel Cervantes, Tegucigalpa, Honduras. 4. Laboratorio Nacional, Tegucigalpa, Honduras. 5. Laboratori Central de Salud Publica de Paraguay, Asuncion, Paraguay. 6. Dirección General de Vigilancia de la Salud, Ministerio de Salud Pública y Bienestar Social, Asunción, Paraguay. 7. Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut 06520-8034, USA.
Abstract
BACKGROUND: Passive surveillance data are often the only available source of data that can be used to evaluate the population-level impact of vaccination, but such data often suffer from important limitations such as changes in surveillance efforts. This study provides an example of how to identify important signatures of rotavirus vaccine impact, including evaluating the overall effectiveness and changes in rotavirus seasonal dynamics. METHODS: We used data from a standardized sentinel rotavirus surveillance network in six Latin American countries (Bolivia, El Salvador, Guatemala, Honduras, Paraguay, and Venezuela) from 2004 to 2017. A random-effects model was used to evaluate changes in the proportion of rotavirus-associated hospitalizations following vaccine introduction. Harmonic regression models were used to estimate vaccine impact on the number of rotavirus hospitalizations, controlling for trends in rotavirus-negative cases. Changes to rotavirus seasonality were evaluated using center of gravity analysis, wavelet analysis, and harmonic regression. RESULTS: All countries observed declines in the proportion of rotavirus-positive acute diarrhea samples with a mean reduction of 16% (95% confidence interval: 10-22%). We estimate that each 10% increase in vaccine coverage was associated with declines in the number of rotavirus-positive cases, ranging from 4.3% (1.3-7.2%) in Honduras to 21.4% (16.8-25.9%) in Venezuela. The strength of the seasonal peak in rotavirus incidence became smaller after vaccine introduction in Guatemala, Honduras, and Venezuela. Seasonal peaks also shifted later in the surveillance year, especially in higher-mortality countries. CONCLUSIONS: The combination of methods we applied have different strengths that allow us to identify common signatures of rotavirus vaccine impact.
BACKGROUND: Passive surveillance data are often the only available source of data that can be used to evaluate the population-level impact of vaccination, but such data often suffer from important limitations such as changes in surveillance efforts. This study provides an example of how to identify important signatures of rotavirus vaccine impact, including evaluating the overall effectiveness and changes in rotavirus seasonal dynamics. METHODS: We used data from a standardized sentinel rotavirus surveillance network in six Latin American countries (Bolivia, El Salvador, Guatemala, Honduras, Paraguay, and Venezuela) from 2004 to 2017. A random-effects model was used to evaluate changes in the proportion of rotavirus-associated hospitalizations following vaccine introduction. Harmonic regression models were used to estimate vaccine impact on the number of rotavirus hospitalizations, controlling for trends in rotavirus-negative cases. Changes to rotavirus seasonality were evaluated using center of gravity analysis, wavelet analysis, and harmonic regression. RESULTS: All countries observed declines in the proportion of rotavirus-positive acute diarrhea samples with a mean reduction of 16% (95% confidence interval: 10-22%). We estimate that each 10% increase in vaccine coverage was associated with declines in the number of rotavirus-positive cases, ranging from 4.3% (1.3-7.2%) in Honduras to 21.4% (16.8-25.9%) in Venezuela. The strength of the seasonal peak in rotavirus incidence became smaller after vaccine introduction in Guatemala, Honduras, and Venezuela. Seasonal peaks also shifted later in the surveillance year, especially in higher-mortality countries. CONCLUSIONS: The combination of methods we applied have different strengths that allow us to identify common signatures of rotavirus vaccine impact.
Authors: Bernard Cazelles; Mario Chavez; Guillaume Constantin de Magny; Jean-Francois Guégan; Simon Hales Journal: J R Soc Interface Date: 2007-08-22 Impact factor: 4.118
Authors: Paul A Gastañaduy; Ingrid Contreras-Roldán; Chris Bernart; Beatriz López; Stephen R Benoit; Marvin Xuya; Fredy Muñoz; Rishi Desai; Osbourne Quaye; Ka Ian Tam; Diana K Evans-Bowen; Umesh D Parashar; Manish Patel; John P McCracken Journal: Clin Infect Dis Date: 2016-05-01 Impact factor: 9.079
Authors: Christian A W Bruhn; Cynthia Schuck-Paim; Esra Kürüm; Robert J Taylor; Lone Simonsen; Daniel M Weinberger Journal: Epidemiology Date: 2017-03 Impact factor: 4.822
Authors: K Zaman; Duc Anh Dang; John C Victor; Sunheang Shin; Md Yunus; Michael J Dallas; Goutam Podder; Dinh Thiem Vu; Thi Phuong Mai Le; Stephen P Luby; Huu Tho Le; Michele L Coia; Kristen Lewis; Stephen B Rivers; David A Sack; Florian Schödel; A Duncan Steele; Kathleen M Neuzil; Max Ciarlet Journal: Lancet Date: 2010-08-06 Impact factor: 79.321
Authors: Virginia E Pitzer; Cécile Viboud; Lone Simonsen; Claudia Steiner; Catherine A Panozzo; Wladimir J Alonso; Mark A Miller; Roger I Glass; John W Glasser; Umesh D Parashar; Bryan T Grenfell Journal: Science Date: 2009-07-17 Impact factor: 47.728
Authors: Orbelina de Palma; Lilian Cruz; Hector Ramos; Amada de Baires; Nora Villatoro; Desiree Pastor; Lucia Helena de Oliveira; Tara Kerin; Michael Bowen; Jon Gentsch; Douglas H Esposito; Umesh Parashar; Jacqueline Tate; Manish Patel Journal: BMJ Date: 2010-06-15
Authors: Timo Vesikari; Robbin Itzler; David O Matson; Mathuram Santosham; Celia D C Christie; Michele Coia; John R Cook; Gary Koch; Penny Heaton Journal: Int J Infect Dis Date: 2007-11 Impact factor: 3.623
Authors: Lucia Helena de Oliveira; M Carolina Danovaro-Holliday; Jon Kim Andrus; Ana Maria Bispo de Fillipis; Jon Gentsch; Cuauhtemoc Ruiz Matus; Marc-Alain Widdowson Journal: J Infect Dis Date: 2009-11-01 Impact factor: 5.226
Authors: Mary E Petrone; Rebecca Earnest; José Lourenço; Moritz U G Kraemer; Robert Paulino-Ramirez; Nathan D Grubaugh; Leandro Tapia Journal: Nat Commun Date: 2021-01-08 Impact factor: 14.919